Kisqali 600 MG Daily Dose Carton Pack

RxCUI: 1873995
RxNorm name: Kisqali 600 MG Daily Dose Carton Pack
Display name: Kisqali 600 MG Daily Dose Carton Pack
Full name: Kisqali 600 MG Daily Dose Carton Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KISQALI	RIBOCICLIB	Novartis Pharmaceuticals Corporation	aaeaef94-f3f5-4367-8ea2-b181d7be2da8	2026-07-01	Warnings, Adverse reactions	Exact identifier rxcui: 1873995

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
aaeaef94-f3f5-4367-8ea2-b181d7be2da8	Kisqali 600 MG Daily Dose Carton Pack	SY	27	These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI ® (ribociclib) tablets, for oral use Initial U.S. Approval: 2017	20251215
aaeaef94-f3f5-4367-8ea2-b181d7be2da8	{63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 600 MG Daily Dose Carton]	BPCK	27	These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI ® (ribociclib) tablets, for oral use Initial U.S. Approval: 2017	20251215
aaeaef94-f3f5-4367-8ea2-b181d7be2da8	Kisqali 600 MG Daily Dose Carton Pack	PSN	27	These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI ® (ribociclib) tablets, for oral use Initial U.S. Approval: 2017	20251215